NLRP3 and lymphedema: For example, Zhou Z et al. reported that substance P, a neurotransmitter, downregulates the NF-κB/NLRP3 pathway to polarize bone marrow-derived macrophages (BMDMs) into M2 macrophages, thereby alleviating secondary lymphedema (Zhou et al., 2023).